Recent cases of criminal attempts to sell falsified and stolen stock into the legitimate supply chain have exposed weaknesses in some supplier qualification processes. A reminder of what companies need to do to protect themselves, the public and the supply chain.
Good manufacturing practice
In today’s computerised, high-tech pharmaceutical environment, it is worth reflecting on the Clothier report conclusions from 47 years ago.
Implementation of the FMD safety features in the UK
The MHRA Laboratories Symposium will be held on 13 March 2019 at the Novotel in London. Also ... we have recently changed the contact email address for the laboratories inspection group from email@example.com to firstname.lastname@example.org
In a bid to drive improved compliance and to cover the cost of managing more resource-intensive cases, the Inspectorate intends to apply the existing office-based assessment fee more broadly.
Q&As clarifying expectations for implementation of the HBEL guide and cross-contamination control requirements were published in April 2018
The Process Licensing Office has today joined the Inspectorate to become the Inspectorate & Process Licensing Group.
From 16 to 18 April 2018 the PIC/S Committee and PIC/S Executive Bureau meetings took place in Geneva, Switzerland.
This post provides guidance around the use of VHP for sterilization purposes
This post provides guidance around the urgent supply of unlicensed medicines that have needed to be imported out of hours by UK hospitals.